Experience with the use of growth hormones in a patient with Cushing's syndrome


  • Kadirova Zarina Subxanovna Bukhara State Medical Institute, Republic of Uzbekistan, Bukhara


Cushing's disease, children, growth retardation, synthetic growth hormone


Cushing’s disease (CD), defined as hypercortisolism caused by excess adrenocorticotropic Hormone (ACTH) secretion by a pituitary corticotroph adenoma, presents rarely in the paediatric age range. However, this serious disorder requires early diagnosis and specialised management because the morbidity related to chronic hypercortisolism in paediatric patients is considerable. Growth retardation to the point of complete cessation of growth is a hallmark of Cushing's syndrome in children. The main mechanism for this is considered to be glucocorticoid-induced resistance of target tissues to insulin-like growth factor 1 (IGF-1) and other growth factors and growth hormone (GH) deficiency. This article describes a case of the use of synthetic growth hormone in a teenager with Cushing's syndrome, a feature of which is the presence of positive dynamics in the patient's growth.


Marova E.I. et al. Itsenko-Cushing’s disease: clinical picture, diagnosis, treatment //Moscow. – 2012. – P. 64.

Biller B. M. K. et al. Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement //The Journal of Clinical Endocrinology & Metabolism. – 2008. – Т. 93. – №. 7. – С. 2454-2462.

Broder M. S. et al. Incidence of Cushing’s syndrome and Cushing’s disease in commercially-insured patients< 65 years old in the United States //Pituitary. – 2015. – Т. 18. – №. 3. – С. 283-289.

Etxabe J., Vazquez J. A. Morbidity and mortality in Cushing's disease: an epidemiological approach //Clinical endocrinology. – 1994. – Т. 40. – №. 4. – С. 479-484.

Lindholm J. et al. Incidence and late prognosis of Cushing’s syndrome: a population-based study //The Journal of Clinical Endocrinology & Metabolism. – 2001. – Т. 86. – №. 1. – С. 117-123.

Nieman L. K. et al. The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline //The Journal of Clinical Endocrinology & Metabolism. – 2008. – Т. 93. – №. 5. – С. 1526-1540.

Sharma S. T., Nieman L. K., Feelders R. A. Cushing’s syndrome: Epidemiology and developments in disease management. Clin. Epidemiol. 7, 281–293. – 2015.




How to Cite

Kadirova Zarina Subxanovna. (2024). Experience with the use of growth hormones in a patient with Cushing’s syndrome. International Journal of Integrative and Modern Medicine, 2(3), 12–15. Retrieved from http://medicaljournals.eu/index.php/IJIMM/article/view/184